Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 79 of 158 for:    interstitial cystitis

A Trial of Intravesical Therapy for Interstitial Cystitis in Patients With Generalized Vulvodynia (VV/IC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01048177
Recruitment Status : Withdrawn
First Posted : January 13, 2010
Last Update Posted : May 13, 2014
Sponsor:
Information provided by (Responsible Party):
Bruce Kahn, Scripps Health

Brief Summary:
In order to investigate whether the pain in women with vulvodynia may represent bladder origin pain, we will be performing a diagnostic test for interstitial cystitis (IC) in women with generalized vulvodynia. Those women with a positive test for IC, we will be performing a series of bladder treatments (instillations) for IC and checking symptoms throughout the trial to see if significant relief of vulvar pain can be obtained through treatment for IC.

Condition or disease Intervention/treatment Phase
Vulvodynia Drug: Bladder instillation with heparin/ lidocaine Phase 2

  Show Detailed Description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 0 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Trial of Intravesical Therapy for Interstitial Cystitis in Patients With Generalized Vulvodynia
Study Start Date : December 2012
Estimated Primary Completion Date : June 2014
Estimated Study Completion Date : June 2014

Resource links provided by the National Library of Medicine

Drug Information available for: Heparin

Arm Intervention/treatment
Experimental: Treatment Drug: Bladder instillation with heparin/ lidocaine
9 bladder instillations in 6 weeks




Primary Outcome Measures :
  1. Reduction in pelvic pain / vulvodynia [ Time Frame: 16 weeks ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • We plan to enroll women 18 years or older with GV and negative tests for urine infection, negative cultures for Chlamydia and gonorrhea when indicated, and negative screens or cultures for yeast infection or bacterial vaginosis when indicated.
  • Patient symptoms will need to include no or minimal vaginal discharge.
  • Patients will have a minimum Visual Analog Score for vulvar pain of at least 3/10.
  • In order to receive bladder instillations, patients will need to have a positive potassium sensitivity test.

Exclusion Criteria:

  • We will exclude patients from enrollment if they use chronic narcotic pain medication or have localized vulvodynia. (We believe that localize vulvodynia is less likely of bladder origin).

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01048177


Locations
Layout table for location information
United States, California
Scripps Clinic
San Diego, California, United States, 92130
Sponsors and Collaborators
Scripps Health
Investigators
Layout table for investigator information
Principal Investigator: Bruce Kahn, M.D. Scripps Clinic

Layout table for additonal information
Responsible Party: Bruce Kahn, MD, Scripps Health
ClinicalTrials.gov Identifier: NCT01048177     History of Changes
Other Study ID Numbers: IRB-09-5381
First Posted: January 13, 2010    Key Record Dates
Last Update Posted: May 13, 2014
Last Verified: May 2014

Keywords provided by Bruce Kahn, Scripps Health:
vulvodynia
interstitial cystitis
pelvic pain

Additional relevant MeSH terms:
Layout table for MeSH terms
Cystitis
Cystitis, Interstitial
Vulvodynia
Urinary Bladder Diseases
Urologic Diseases
Vulvar Diseases
Genital Diseases, Female
Heparin
Anticoagulants
Fibrinolytic Agents
Fibrin Modulating Agents
Molecular Mechanisms of Pharmacological Action